Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent

被引:25
作者
Daniels, I
Lindsay, MA
Keany, CIC
Burden, RP
Fletcher, J
Haynes, AP
机构
[1] City Hosp Nottingham, Med Res Ctr, Nottingham NG5 1PB, England
[2] City Hosp Nottingham, Dept Renal Med, Nottingham NG5 1PB, England
关键词
D O I
10.1128/CDLI.5.5.683-689.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peritoneal dialysis effluent (PDE) contains a low-molecular-weight solute that will activate and prime the NADPH oxidase of human neutrophils via a phospholipase A(2) (PLA(2))-dependent mechanism. Since the products of PLA(2) are known to activate and prime the oxidase we have investigated their role in the dialysis effluent-mediated activation and priming of human neutrophils. NADPH oxidase activity of PDE-primed and -unprimed neutrophils was measured by lucigenin-enhanced chemiluminescence in the presence of known inhibitors of the arachidonic acid cascade. Incubation of neutrophils with the nonselective PLA(2) inhibitor quinacrine (0 to 100 mu M) reduced oxidase activity in both primed and unprimed cells. Furthermore, primed cells were more sensitive to the action of quinacrine than were unprimed cells, We were unable to determine the relative roles of secretory PLA(2) (sPLA(2)) and cytosolic PLA(2) (cPLA(2)) since the selective sPLA(2) inhibitor scalaradial (0 to 100 mu M) inhibited oxidase activity in both groups of cells by similar degrees, while the specific cPLA(2) inhibitor AACO-CF3 (0 to 50 mu M) failed to affect activity in either group. Inhibition of platelet-activating factor (PAF), cycloxygenase, and 5-lipoxygenase-activating protein by hexanolamino-PAF (0 to 25 mu M), flurbiprofen (0 to 25 mu M), and MK886 (0 to 5 mu M), respectively, had no effect upon oxidase activity. However, the direct inhibition of 5-lipoxygenase by caffeic acid or lipoxin A(4) resulted in a similar concentration-dependent attenuation of oxidase activity in both primed and unprimed cells. Leukotriene B-4 (LTB4) release from primed neutrophils was comparable to that from unprimed cells with the exception of phorbol myristate acetate-stimulated cells, which released fivefold more LTB4 than control. Taken together, these results suggest that it is arachidonic acid per se, and not its metabolites, that is important in priming of the neutrophil NADPH oxidase by dialysis effluent.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 52 条
[1]   INHIBITION OF NEUTROPHIL RESPIRATORY BURST AND DEGRANULATION RESPONSES TO PLATELET-ACTIVATING-FACTOR BY ANTAGONISTS WEB-2086, CV-6209 AND CV-3988 [J].
BATES, EJ ;
HARVEY, DP ;
FERRANTE, A .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 97 (01) :50-56
[2]  
BAULDRY SA, 1988, J BIOL CHEM, V263, P16787
[3]  
BAULDRY SA, 1991, J IMMUNOL, V146, P1277
[4]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[5]  
CLASSON HE, 1981, BIOCHEM BIOPH RES CO, V99, P1230
[6]   INHIBITION OF LEUKOTRIENE-B4 IN NEUTROPHILS BY LIPOXIN-A4 AND LIPOXIN-B4 [J].
CONTI, P ;
REALE, M ;
BARBACANE, RC ;
PANARA, MR ;
BONGRAZIO, M .
AGENTS AND ACTIONS, 1991, 32 (1-2) :85-87
[7]   THE USE OF ATP BIOLUMINESCENCE AS A MEASURE OF CELL-PROLIFERATION AND CYTOTOXICITY [J].
CROUCH, SPM ;
KOZLOWSKI, R ;
SLATER, KJ ;
FLETCHER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 160 (01) :81-88
[8]   LEUKOTRIENE PRODUCTION IN HUMAN-NEUTROPHILS PRIMED BY RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND STIMULATED WITH THE COMPLEMENT COMPONENT C5A AND FMLP AS 2ND SIGNALS [J].
DAHINDEN, CA ;
ZINGG, J ;
MALY, FE ;
DEWECK, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1281-1295
[9]   EFFECT OF PERITONEAL-DIALYSIS EFFLUENT ON SUPEROXIDE ANION PRODUCTION BY POLYMORPHONUCLEAR NEUTROPHILS [J].
DANIELS, I ;
LINDSAY, M ;
PORTER, C ;
HAYNES, AP ;
FLETCHER, J ;
MORGAN, AG .
NEPHRON, 1993, 64 (03) :382-387
[10]   Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent [J].
Daniels, I ;
Bhatia, KSS ;
Porter, CJ ;
Lindsay, MA ;
Morgan, AG ;
Burden, RP ;
Fletcher, J .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (06) :682-688